Protara Therapeutics (TARA) Change in Acquisitions & Divestments (2014 - 2026)

Protara Therapeutics' Change in Acquisitions & Divestments history runs 11 years deep, the most recent figure standing at $29.1 million for Q1 2026.

• In Q1 2026, Change in Acquisitions & Divestments rose 288.48% year-over-year to $29.1 million; the TTM figure through Mar 2026 stood at $86.9 million (up 163.24% YoY), while the FY2025 annual figure was $65.2 million, up 34.23% from the prior year.
• Change in Acquisitions & Divestments was $29.1 million for Q1 2026 at Protara Therapeutics, down from $35.8 million in the prior quarter.
• In the past five years, Change in Acquisitions & Divestments ranged from a high of $35.8 million in Q4 2025 to a low of $3.0 million in Q2 2024.
• Historically, Change in Acquisitions & Divestments has averaged $17.0 million across 5 years, with a median of $18.5 million in 2022.
• The sharpest annual moves came in 2024 and 2026: Change in Acquisitions & Divestments slumped 86.58% in 2024, then soared 288.48% in 2026.
• A 5-year view of Change in Acquisitions & Divestments shows it stood at $10.8 million in 2022, then surged by 34.64% to $14.5 million in 2023, then surged by 54.98% to $22.5 million in 2024, then soared by 59.22% to $35.8 million in 2025, then slipped by 18.67% to $29.1 million in 2026.
• The last three Change in Acquisitions & Divestments figures came in at $29.1 million (Q1 2026), $35.8 million (Q4 2025), and $17.9 million (Q3 2025), per Business Quant data.